Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Selective Advantage of the Recurrent Isodicentric Chromosome 20 in Myeloid Disease

Justin B Schleede, PhD, Peter Papenhausen, PhD, Stuart Schwartz, PhD, Inder K. Gadi, PhD

Blood (2016) 128 (22): 5119.

https://doi.org/10.1182/blood.V128.22.5119.5119

Published: 2016

Journal Articles

The Impact of 20q Deletion on Clinical Presentation, Treatment Response and Survival in Patients with Acute Myeloid Leukemia (AML): The University of Texas MD Anderson Cancer Center Experience

Jad Chahoud, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Koji Sasaki, MD, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Tapan Kadia, MD, Mark Brandt, BS, Elias Jabbour

Blood (2015) 126 (23): 1369.

https://doi.org/10.1182/blood.V126.23.1369.1369

Published: 2015

Journal Articles

The Phenotype of Human STK4 Deficiency

Hengameh Abdollahpour, MD, PhD, Giridharan Appaswamy, PhD, Rita Beier, MD, Alejandro A. Schäffer, PhD, E. Michael Gertz, PhD, Hans H. Kreipe, MD, Dietmar Pfeifer, PhD, Bodo Grimbacher, MD, Sabine Lohrmann, MD, Roya Sherkat, MD, Christoph Klein, MD, PhD

Blood (2011) 118 (21): 692.

https://doi.org/10.1182/blood.V118.21.692.692

Published: 2011

Journal Articles

Detection of Novel Mutations In MDS/AML by Whole Genome Sequencing

Blood (2010) 116 (21): 299.

https://doi.org/10.1182/blood.V116.21.299.299

Published: 2010

Journal Articles

Semg 1 Expression in Early Chronic Lymphocytic Leukemia

Farouk Meklat, BS, Sharif Uddin Ahmed, PhD, Masum Shahriar, MSc, Jian Zhang, BA, Suhkrob Mastulov, MD, Thomas Giannakouros, PhD, Andrew Jewell, PhD, Yana Zhang, MD, PhD, Seah H. Lim, MD, PhD

Blood (2008) 112 (11): 4175.

https://doi.org/10.1182/blood.V112.11.4175.4175

Published: 2008

Journal Articles

Definition of Commonly Deleted Regions and Identification of Candidate Genes of Chromosome 20 in Myeloid Malignancies Using Genome-Wide Single Nucleotide Polymorphism (SNP) Array.

Jungwon Huh, MD, Ramon V. Tiu, MD, BS, Ying Jiang, MD, PhD, Lukasz P Gondek, MD, PhD, Christine O’Keefe, PhD, Karl S. Theil, MD, Jaroslaw P Maciejewski, MD, PhD

Blood (2008) 112 (11): 2056.

https://doi.org/10.1182/blood.V112.11.2056.2056

Published: 2008

NARROW

Selective Advantage of the Recurrent Isodicentric Chromosome 20 in Myeloid Disease

The Impact of 20q Deletion on Clinical Presentation, Treatment Response and Survival in Patients with Acute Myeloid Leukemia (AML): The University of Texas MD Anderson Cancer Center Experience

The Phenotype of Human STK4 Deficiency

Detection of Novel Mutations In MDS/AML by Whole Genome Sequencing

Semg 1 Expression in Early Chronic Lymphocytic Leukemia

Definition of Commonly Deleted Regions and Identification of Candidate Genes of Chromosome 20 in Myeloid Malignancies Using Genome-Wide Single Nucleotide Polymorphism (SNP) Array.

Email alerts

ASH Publications

American Society of Hematology

Selective Advantage of the Recurrent Isodicentric Chromosome 20 in Myeloid Disease

The Impact of 20q Deletion on Clinical Presentation, Treatment Response and Survival in Patients with Acute Myeloid Leukemia (AML): The University of Texas MD Anderson Cancer Center Experience

The Phenotype of Human STK4 Deficiency

Detection of Novel Mutations In MDS/AML by Whole Genome Sequencing

Semg 1 Expression in Early Chronic Lymphocytic Leukemia

Definition of Commonly Deleted Regions and Identification of Candidate Genes of Chromosome 20 in Myeloid Malignancies Using Genome-Wide Single Nucleotide Polymorphism (SNP) Array.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only